Vps41 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
VPS41 encodes vacuolar protein sorting 41, a core subunit of the HOPS complex that drives membrane tethering and fusion at the late endosome-lysosome interface.[1][2] In neurons, this fusion step is essential for completing autophagic flux, degrading damaged proteins and organelles, and maintaining axonal and synaptic homeostasis.[3][4] Because neurodegenerative disorders frequently converge on endolysosomal failure, VPS41 has become a mechanistically important gene linking trafficking defects to neuronal vulnerability.[3:1][5]
VPS41 operates in the HOPS tethering complex with VPS16, VPS18, VPS33A, VPS11, and VPS39.[1:1][2:1] The complex recognizes Rab-positive late endosomal and lysosomal membranes, positions them for fusion, and coordinates productive SNARE-mediated membrane merger.[1:2][2:2]
A critical assembly feature is the VPS18-VPS41 interaction through C-terminal RING domains, which helps recruit and stabilize VPS41 within human HOPS.[6] This structural logic is important because partial destabilization of HOPS can reduce fusion efficiency without fully abolishing organelle identity, creating chronic "traffic jams" in post-mitotic neurons.[5:1][6:1]
Autophagy requires stepwise progression from phagophore formation to autophagosome closure and finally lysosomal fusion. VPS41 contributes to the terminal phase, where late autophagosomes fuse with lysosomes for cargo degradation.[1:3][3:2] When this step is compromised, cells accumulate undegraded cargo, enlarged endolysosomal compartments, and persistent stress signaling.[3:3][4:1]
In neurons, defective terminal fusion has outsized consequences because long-lived proteins, synaptic vesicle components, and damaged mitochondria must be continuously cleared over decades.[3:4][4:2] This makes VPS41 function directly relevant to pathways discussed in mitophagy, protein aggregation, and lysosomal dysfunction.
Biallelic loss-of-function variants in VPS41 were reported in early-onset dystonia with lysosomal abnormalities, extending the list of neurologic syndromes caused by HOPS-complex disruption.[7] Clinical phenotypes often include developmental motor abnormalities and progressive movement dysfunction, consistent with high neuronal dependence on intact endolysosomal fusion.[7:1][8]
Beyond Mendelian VPS41 disease, the VPS41 node maps onto broader neurodegenerative biology. Endolysosomal bottlenecks are strongly implicated in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal dementia through failed proteostasis and inflammatory amplification.[3:5][4:3][5:2]
Because HOPS interacts functionally with Rab-mediated trafficking, VPS41 dysfunction can propagate to impaired degradative signaling, defective organelle quality control, and altered lysosome-dependent transcriptional programs.[5:3][8:1]
In AD-relevant models, inefficient endolysosomal clearance can increase residence time of APP-processing intermediates and aggregated proteins, feeding a cycle of stress and impaired clearance.[3:6][4:4] In PD-relevant systems, defective autophagosome maturation can reduce turnover of aggregation-prone proteins and damaged mitochondria, increasing vulnerability of dopaminergic neurons with high metabolic demand.[3:7][4:5]
VPS41 should therefore be viewed as an upstream trafficking control point rather than a disease-specific gene: subtle deficits can tune risk across multiple disorders by shifting the baseline efficiency of neuronal waste clearance.[5:4][8:2]
Current translational strategies around VPS41 biology focus on pathway-level rescue rather than direct gene-specific drugs. Candidate directions include:
Experimentally, VPS41 provides a useful perturbation node for dissecting when autophagic failure becomes irreversible in vulnerable neuronal populations. Integrating VPS41 genotype, lysosomal biomarkers, and imaging-based flux assays may improve patient stratification for therapies targeting the autophagy-lysosomal system.[3:8][5:5]
The study of Vps41 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Balderhaar HJK, Ungermann C. CORVET and HOPS tethering complexes coordinators of endosome and lysosome fusion. Journal of Cell Science. 2013. ↩︎ ↩︎ ↩︎ ↩︎
Br\xf6cker C, Kuhlee A, Gatsogiannis C, et al. Molecular architecture of the multisubunit homotypic fusion and vacuole protein sorting (HOPS) tethering complex. Proceedings of the National Academy of Sciences. 2012. ↩︎ ↩︎ ↩︎
Nixon RA. The role of autophagy in neurodegenerative disease. Nature Medicine. 2013. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nature Reviews Neuroscience. 2015. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
van der Beek J, Jonker CTH, van der Welle REN, Liv N, Klumperman J. CORVET, CHEVI and HOPS multisubunit tethers of the endo-lysosomal system in health and disease. Journal of Cell Science. 2021. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Hunter MR, Scourfield EJ, Emmott E, Graham SC. VPS18 recruits VPS41 to the human HOPS complex via a RING-RING interaction. Biochemical Journal. 2017. ↩︎ ↩︎
Steel D, Zech M, Zhao C, et al. Loss-of-Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities. Annals of Neurology. 2020. ↩︎ ↩︎
van der Beek J, Meyen S, Hrab\xe1lkova L, et al. Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1-dependent TFEB/TFE3 regulation. EMBO Molecular Medicine. 2021. ↩︎ ↩︎ ↩︎